GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | January 08, 2025 |
PDB ID | UniProt ID ▲ | Title | Descriptor |
---|---|---|---|
3ODY | Q16539 | Crystal structure of p38alpha Y323Q active mutant | |
3ODZ | Q16539 | Crystal structure of P38alpha Y323R active mutant | |
3OEF | Q16539 | Crystal structure of Y323F inactive mutant of p38alpha MAP kinase | |
3PG3 | Q16539 | Human p38 MAP Kinase in Complex with RL182 | |
3QUD | Q16539 | Human p38 MAP Kinase in Complex with 2-amino-phenylamino-benzophenone | |
3QUE | Q16539 | Human p38 MAP Kinase in Complex with Skepinone-L | |
3UVP | Q16539 | Human p38 MAP Kinase in Complex with a Benzamide Substituted Benzosuberone | |
3UVQ | Q16539 | Human p38 MAP Kinase in Complex with a Dibenzosuberone Derivative | |
3UVR | Q16539 | Human p38 MAP Kinase in Complex with KM064 | |
3ZS5 | Q16539 | Structural basis for kinase selectivity of three clinical p38alpha inhibitors | |
3ZSG | Q16539 | X-ray structure of p38alpha bound to TAK-715 | |
3ZSH | Q16539 | X-ray structure of p38alpha bound to SCIO-469 | |
3ZSI | Q16539 | X-ray structure of p38alpha bound to VX-745 | |
4GEO | Q16539 | P38a MAP kinase DEF-pocket penta mutant (M194A, L195A, H228A, I229A, Y258A) | |
4L8M | Q16539 | Human p38 MAP kinase in complex with a Dibenzoxepinone | |
5ML5 | Q16539 | Human p38alpha MAPK in complex with imidazolyl pyridine inhibitor 11b | |
5MTX | Q16539 | Dibenzooxepinone inhibitor 12b in complex with p38 MAPK | |
5MTY | Q16539 | Dibenzosuberone inhibitor 8e in complex with p38 MAPK | |
5OMG | Q16539 | p38alpha in complex with pyrazolobenzothiazine inhibitor COXP4M12 | |
4HSA | Q16552 | Structure of interleukin 17a in complex with il17ra receptor | |
5N92 | Q16552 | Crystal Structure of Human IL-17AF | |
5NAN | Q16552 | Crystal Structure of human IL-17AF in complex with human IL-17RA | |
7UWM | Q16552 | Structure of the IL-17A-IL-17RA binary complex | |
7UWN | Q16552 | Structure of the IL-17A-IL-17RA-IL-17RC ternary complex | |
7ZAN | Q16552 | Crystal Structure of human IL-17A in complex with IL-17RA and IL-17RC | |
6D1U | Q16602 | Crystal structure of the human CLR:RAMP1 extracellular domain heterodimer in complex with adrenomedullin 2/intermedin | |
6ZHO | Q16602 | Crystal structure of a CGRP receptor ectodomain heterodimer with bound high affinity inhibitor | |
6ZIS | Q16602 | Crystal structure of a CGRP receptor ectodomain heterodimer with bound high affinity inhibitor | |
5V6Y | Q16602 | Crystal structure of the human CLR:RAMP1 extracellular domain heterodimer with bound high-affinity and altered selectivity adrenomedullin variant | |
6V2E | Q16602 | Crystal structure of the human CLR:RAMP2 extracellular domain heterodimer with bound high-affinity adrenomedullin S45R/K46L/S48G/Q50W variant | |
7P0F | Q16602 | Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor HTL0028125 | |
7P0I | Q16602 | Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor Compound 13 | |
4RWF | Q16602 | Crystal structure of the CLR:RAMP2 extracellular domain heterodimer with bound adrenomedullin | |
4RWG | Q16602 | Crystal structure of the CLR:RAMP1 extracellular domain heterodimer with bound high affinity CGRP analog | |
8AX5 | Q16602 | Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor HTL0029881 | |
8AX6 | Q16602 | Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor HTL0029882 | |
8AX7 | Q16602 | Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor HTL0031448 | |
6UXO | Q16611 | Crystal structure of BAK core domain BH3-groove-dimer in complex with DDM | |
2FO4 | Q16615 | Enhanced MHC class I binding and immune responses through anchor modification of the non-canonical tumor associated MUC1-8 peptide | |
3B6H | Q16647 | Crystal structure of human prostacyclin synthase in complex with inhibitor minoxidil | |
7L0J | Q16671 | Structure of AMH bound to AMHR2-ECD | |
5SC8 | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 17 | |
5SC9 | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 29 | |
5SCA | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 36 | |
5SCB | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 28 | |
5SCC | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 57 | |
5SCD | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 58 | |
5SCE | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 55 | |
5SCF | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 99 | |
5SCG | Q16716 | Structure of liver pyruvate kinase in complex with anthraquinone derivative 101 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024